ConductScience.org, home

Paper28693269

Significance of E-cadherin and CD44 expression in patients with unresectable metastatic colorectal cancer.

Iseki Y and 5 others. Oncol Lett, 2017. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Significance of E-cadherin and CD44 expression in patients with unresectable metastatic colorectal cancer. Papers, record 28693269. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28693269

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Significance of E-cadherin and CD44 expression in patients with unresectable metastatic colorectal cancer.
PubMed
Journal
Oncol Lett
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.69
iCite
Revised in PubMed
2020-10-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Iseki YYasuhito
2Shibutani MMasatsune
3Maeda KKiyoshi
4Nagahara HHisashi
5Ikeya TTetsuro
6Hirakawa KKosei

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121678109Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma.Pathol Oncol Res2011https://conductscience.org/library/papers/21678109PubMed
29395530Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44.J Biol Chem1997https://conductscience.org/library/papers/9395530PubMed
38780391Progressive loss of CD44 gene expression in invasive bladder cancer.Am J Pathol1996https://conductscience.org/library/papers/8780391PubMed
412398894A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor.Cancer Cell2002https://conductscience.org/library/papers/12398894PubMed
516857785Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.Clin Cancer Res2006https://conductscience.org/library/papers/16857785PubMed
624503029Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project.Jpn J Clin Oncol2014https://conductscience.org/library/papers/24503029PubMed
72193100Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.J Exp Med1990https://conductscience.org/library/papers/2193100PubMed
811733201Tumor environment: a potent driving force in colorectal cancer?Trends Mol Med2001https://conductscience.org/library/papers/11733201PubMed
919262571Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.Nat Rev Cancer2009https://conductscience.org/library/papers/19262571PubMed
1010931041E-cadherin-catenin cell-cell adhesion complex and human cancer.Br J Surg2000https://conductscience.org/library/papers/10931041PubMed
1123923027Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis.PLoS One2013https://conductscience.org/library/papers/23923027PubMed
1225088940FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial.Lancet Oncol2014https://conductscience.org/library/papers/25088940PubMed
139155672Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes' B colorectal cancers.J Clin Pathol1997https://conductscience.org/library/papers/9155672PubMed
1422692571Prognostic scoring system for stage IV colorectal cancer: is the AJCC sub-classification of stage IV colorectal cancer appropriate?Int J Clin Oncol2013https://conductscience.org/library/papers/22692571PubMed
152466576A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins.Cell1989https://conductscience.org/library/papers/2466576PubMed
1617673689Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling.Am J Respir Cell Mol Biol2008https://conductscience.org/library/papers/17673689PubMed
1718322269Cadherin switching.J Cell Sci2008https://conductscience.org/library/papers/18322269PubMed
1810211089Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling.Eur J Cancer1999https://conductscience.org/library/papers/10211089PubMed
192056274Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.J Exp Med1991https://conductscience.org/library/papers/2056274PubMed
2015339042CD44 in cancer progression: adhesion, migration and growth regulation.J Mol Histol2004https://conductscience.org/library/papers/15339042PubMed

See all 40 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
41413092CD44 and phosphorylated ERK1/2 coexpression predicts distant metastasis in colorectal cancer based on a study of 1137 Saudi patients.Sci Rep2025https://conductscience.org/library/papers/41413092PubMed
39174579The use of hyaluronic acid in a 3D biomimetic scaffold supports spheroid formation and the culture of cancer stem cells.Sci Rep2024https://conductscience.org/library/papers/39174579PubMed
37012965Association Between the Immunohistochemistry Expression of E-cadherin, Beta-Catenin, and CD44 in Colorectal Adenocarcinoma.Cureus2023https://conductscience.org/library/papers/37012965PubMed
35732878Effect of E-cadherin on Prognosis of Colorectal Cancer: A Meta-Analysis Update.Mol Diagn Ther2022https://conductscience.org/library/papers/35732878PubMed
33817713Assessment of mismatch repair deficiency, CDX2, beta-catenin and E-cadherin expression in colon cancer: molecular characteristics and impact on prognosis and survival - an immunohistochemical study.Rom J Morphol Embryol2020https://conductscience.org/library/papers/33817713PubMed
33123252Tumour stem cell markers CD133 and CD44 are useful prognostic factors after surgical resection of pancreatic neuroendocrine tumours.Oncol Lett2020https://conductscience.org/library/papers/33123252PubMed
32392708The Extracellular Matrix Influences Ovarian Carcinoma Cells' Sensitivity to Cisplatinum: A First Step towards Personalized Medicine.Cancers (Basel)2020https://conductscience.org/library/papers/32392708PubMed
32025858Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact.Surg Today2020https://conductscience.org/library/papers/32025858PubMed
32021376The Association Between Inflammation, Epithelial Mesenchymal Transition and Stemness in Colorectal Carcinoma.J Inflamm Res2020https://conductscience.org/library/papers/32021376PubMed
31942198Death Domain-Associated Protein Promotes Colon Cancer Metastasis through Direct Interaction with ZEB1.J Cancer2020https://conductscience.org/library/papers/31942198PubMed
31114754The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis.Front Oncol2019https://conductscience.org/library/papers/31114754PubMed
30717315Potential Applications of DNA, RNA and Protein Biomarkers in Diagnosis, Therapy and Prognosis for Colorectal Cancer: A Study from Databases to AI-Assisted Verification.Cancers (Basel)2019https://conductscience.org/library/papers/30717315PubMed
30021598Evaluation of the correlation of MACC1, CD44, Twist1, and KiSS-1 in the metastasis and prognosis for colon carcinoma.Diagn Pathol2018https://conductscience.org/library/papers/30021598PubMed
30008850Significance and prognosis of epithelial-cadherin expression in invasive breast carcinoma.Oncol Lett2018https://conductscience.org/library/papers/30008850PubMed
29115580Overexpression of CCDC34 in colorectal cancer and its involvement in tumor growth, apoptosis and invasion.Mol Med Rep2018https://conductscience.org/library/papers/29115580PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD44960PubTator's text mininghttps://conductscience.org/library/genes/960NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28693269

GET https://conductscience.org/api/papers/v1/28693269/references?page=2